Drug Profile
PF 6273340
Alternative Names: PF-06273340; PF-6273340Latest Information Update: 11 Feb 2015
Price :
$50
*
At a glance
- Originator Pfizer
- Class Analgesics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 06 Oct 2014 Pfizer plans a phase I trial in Pain (In volunteers) in the Netherlands (NCT02260947)
- 07 Aug 2014 Discontinued - Phase-I for Pain (In volunteers) in Belgium (PO)
- 07 Aug 2014 Discontinued - Phase-I for Pain (In volunteers) in Singapore (PO)